Full Press Release Details
| Alberta Securities Commission | |
| British Columbia Securities Commission | |
| Ontario Securities Commission |
RE: Xenon Pharmaceuticals Inc.
Pursuant to a request from the above-mentioned reporting issuer, we wish to advise you of the following information in connection with its Annual Meeting of Shareholders:
| Date of meeting: | June 2, 2016 |
| Record date for notice: | April 4, 2016 |
| Record date for voting: | April 4, 2016 |
| Beneficial ownership determination date: | April 4, 2016 |
| Securities entitled to notice: | Common Shares |
| Securities entitled to vote: | Common Shares |
| Issuer mailing directly to non objecting beneficial owners: | No |
| Issuer will pay for objecting beneficial owner material distribution: | Yes |
| Issuer using notice-and-access for registered investors: | No |
| Issuer using notice-and-access for non-registered investors: | No |
| Notice-and-access stratification criteria: | N/A |
/s/ Joshua P. McGinn
Senior Vice-President, Western Region
Relationship Management